We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase II trial of the pan-deacetylase inhibitor panobinostat as a single agent in advanced relapsed/refractory multiple myeloma.AuthorsWolf JL; Siegel D; Goldschmidt H; Hazell K; Bourquelot PM; Bengoudifa BR; Matous J; Vij R; de Magalhaes-Silverman M; Abonour R; Anderson KC; Lonial SPublicationLeukemia & lymphoma, 2012, Vol 53, Issue 9, p1820ISSN1029-2403Publication typearticleDOI10.3109/10428194.2012.661175